Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Caligenix
AddedFeb 18, 2024
UpdatedJun 18, 2026
Caligenix

Caligenix

Seed

Caligenix®: A Los Angeles-based company specializing in genetic-based health and wellness.

HQ
Los Angeles, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Caligenix, founded in Los Angeles, is a pioneering genetic-based lifestyle, health, and wellness company. Their core mission is to harness the power of genomics and technology to deliver personalized health solutions. Caligenix offers a unique DNA + RNA biomarker test, supported by a fully automated robotics lab and AI-driven personalized recommendations. The company focuses on empowering wellness product brands with genomic insights to enhance customer health and well-being.

Notable figures associated with Caligenix include experts in genomics and AI technology. The company has achieved significant milestones, such as developing the first-of-its-kind biomarker test and establishing a globally recognized robotics lab. Their innovative approach has made a substantial impact on the wellness industry, providing brands with the tools needed for evidence-based health improvements.

Caligenix - Similar Companies

LifeNome logo

LifeNome

Geneicd logo

Geneicd

Heligenics logo

Heligenics

heligenics.com

Clear Labs logo

Clear Labs

clearlabs.com

Genomenon logo

Genomenon

genomenon.com

GeneDx Holdings logo

GeneDx Holdings

genedx.com

Genetica logo

Genetica

genetica.asia

Helix logo

Helix

Novogenia logo

Novogenia

novogenia.com

Nest Genomics logo

Nest Genomics

nestgenomics.com

PanGenX logo

PanGenX

Maverix Biomics logo

Maverix Biomics

maverixbio.com

Singular Genomics logo

Singular Genomics

Fulgent Diagnostics logo

Fulgent Diagnostics

Pathway Genomics logo

Pathway Genomics

Caligenix - Quick Facts

Who are Caligenix's competitors?

Companies similar to Caligenix include LifeNome, Geneicd, Heligenics and Clear Labs.

When was Caligenix founded?

Caligenix was founded in 2017.

Where is Caligenix's headquarters located?

Caligenix's headquarters is located in Los Angeles, CA, US.

When was Caligenix's last funding round?

Caligenix's most recent funding round was for $720k (USD) in May 2020.

How much has Caligenix raised to-date?

As of May 12, 2020, Caligenix has raised a total of $720k (USD).

How many employees does Caligenix have?

Caligenix has 9 employees as of Feb 4, 2024.

Caligenix - Classification

Technology
  • AI
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Genomics
  • Wellness
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software